Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and<i>Vibrio cholerae</i>α- and β-class enzymes
Silvia Bua(University of Florence), Claudiu T. Supuran(University of Florence), Emanuela Berrino(Link Campus University), Clemente Capasso(Institute of Biosciences and Bioresources), V. Vijayakumar(Vellore Institute of Technology University), Sonia Del Prete(Institute of Biosciences and Bioresources), Vallabhaneni S. Murthy(Vellore Institute of Technology University), Fabrizio Carta(University of Florence), Alessandro Mugelli(University of Florence), Elisabetta Cerbai(University of Florence), Yasinalli Tamboli(King Saud bin Abdulaziz University for Health Sciences)
Cited by 15
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Interfering with pH regulation in tumours as a therapeutic strategy
|Nature Reviews Drug Discovery|2011|1.5k
How many carbonic anhydrase inhibition mechanisms exist?
|Journal of Enzyme Inhibition and Medicinal Chemistry|2015|724
Structure-based drug discovery of carbonic anhydrase inhibitors
|Journal of Enzyme Inhibition and Medicinal Chemistry|2012|608